JiangSu WuZhong Pharmaceutical Development Co., Ltd.
SHH: 600200.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Qunshan Qian
- Employees
- 1,096
- Headquarters
- Suzhou, China
- IPO year
- 1999
- Market cap
- CN¥206.2M
- Website
- https://www.600200.com
Loading 600200…
Loading profile data…Frequently asked questions about 600200
What does JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS) do?
JiangSu WuZhong Pharmaceutical Development Co., Ltd., together with its subsidiaries, engages in pharmaceutical, real estate, and chemical businesses in China. It develops, produces, and sells anti-infective, digestive system, cardiovascular, cerebrovascular, antiviral, vitamin, and hemostatic drugs; and immunomodulations, including biopharmaceu...
Where does 600200.SS trade?
JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS) trades on the Shanghai Stock Exchange.
What sector is 600200.SS in?
JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of JiangSu WuZhong Pharmaceutical Development Co., Ltd.?
Qunshan Qian is the chief executive officer of JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS).
Where is JiangSu WuZhong Pharmaceutical Development Co., Ltd. headquartered?
JiangSu WuZhong Pharmaceutical Development Co., Ltd. is headquartered in China.
Does 600200.SS pay a dividend?
JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 600200.SS go public?
JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS) completed its initial public offering in 1999.